SILVERARC CAPITAL MANAGEMENT, LLC
13F filer · CIK 1816307 · Boston, MA
Summary
SILVERARC CAPITAL MANAGEMENT, LLC reported $962.15M across 73 positions in its 13F for 2026 Q2, filed Aug 13, 2026. The largest holdings are ASND (5.7%), CELC (5.4%), COGT (5.2%). Versus 2026 Q1, leaving options aside, it opened 20 new positions, added to 16, trimmed 27 and sold out of 22.
Reported value$962.15M
Positions73incl. options
Report period2026 Q2
FiledAug 13, 2026
New positions20
Added16
Trimmed27
Sold out22
Top 25 holdings
By reported value, options listed separately · change vs 2026 Q1
Weight 5.7%Value $55.01MPrice $228.07Shares 206KSince Jun 30 -14.49%
Weight 5.4%Value $52.41MPrice $77.38Shares 501K +39.98%Since Jun 30 -26.04%
Weight 5.2%Value $49.56MPrice $31.66Shares 1.28M -2.55%Since Jun 30 -18.19%
Weight 5.0%Value $47.91MPrice $40.45Shares 1.30M -13.38%Since Jun 30 +9.92%
Weight 4.4%Value $42.74MPrice $21.89Shares 2.02M +9.01%Since Jun 30 +3.30%
Weight 4.0%Value $38.02MPrice $87.16Shares 390K -40.43%Since Jun 30 -10.59%
Weight 3.6%Value $34.58MPrice $95.71Shares 311K +1.78%Since Jun 30 -13.80%
Weight 3.5%Value $33.58MPrice $82.15Shares 353K +133.79%Since Jun 30 -13.68%
Weight 2.8%Value $26.82MPrice $11.74Shares 1.11M -44.64%Since Jun 30 -51.49%
Weight 2.8%Value $26.55MPrice $18.24Shares 1.21M +36.60%Since Jun 30 -16.58%
Weight 2.6%Value $24.84MPrice $46.51Shares 489KSince Jun 30 -8.35%
Weight 2.5%Value $23.85MPrice $33.46Shares 619K +49.45%Since Jun 30 -13.16%
Weight 2.4%Value $23.14MPrice $14.21Shares 1.26M -31.80%Since Jun 30 -22.43%
Weight 2.4%Value $22.63MPrice $9.33Shares 2.93MSince Jun 30 +20.70%
Weight 2.3%Value $22.60MPrice $98.50Shares 170K -43.94%Since Jun 30 -26.08%
Weight 2.3%Value $21.99MPrice $281.00Shares 66K -8.21%Since Jun 30 -16.07%
Weight 2.2%Value $21.28MPrice $91.12Shares 546K -44.93%Since Jun 30 +133.88%
Weight 2.0%Value $18.82MPrice $38.21Shares 400KSince Jun 30 -18.77%
Weight 1.9%Value $18.68MPrice $46.08Shares 318K +76.96%Since Jun 30 -21.54%
Weight 1.6%Value $14.98MPrice $177.73Shares 100K +1.33%Since Jun 30 +18.46%
Weight 1.5%Value $14.16MPrice $3.13Shares 3.03M +58.60%Since Jun 30 -32.98%
Weight 1.3%Value $12.94MPrice $26.76Shares 510K -55.12%Since Jun 30 +5.44%
Weight 1.3%Value $12.65MPrice $14.42Shares 678K +32.67%Since Jun 30 -22.68%
Weight 1.3%Value $12.53MPrice $10.74Shares 1.18M -2.58%Since Jun 30 +0.94%
Weight 1.2%Value $11.89MPrice $1.35Shares 5.74MSince Jun 30 -34.78%
| Stock | Weight | Value | Since Jun 30 | Shares change | Action |
|---|---|---|---|---|---|
| 5.7% | $55.01M | -14.49% | — | New | |
| 5.4% | $52.41M | -26.04% | +39.98% | Add | |
| 5.2% | $49.56M | -18.19% | -2.55% | Trim | |
| 5.0% | $47.91M | +9.92% | -13.38% | Trim | |
| 4.4% | $42.74M | +3.30% | +9.01% | Add | |
| 4.0% | $38.02M | -10.59% | -40.43% | Trim | |
| 3.6% | $34.58M | -13.80% | +1.78% | Add | |
| 3.5% | $33.58M | -13.68% | +133.79% | Add | |
| 2.8% | $26.82M | -51.49% | -44.64% | Trim | |
| 2.8% | $26.55M | -16.58% | +36.60% | Add | |
| 2.6% | $24.84M | -8.35% | — | New | |
| 2.5% | $23.85M | -13.16% | +49.45% | Add | |
| 2.4% | $23.14M | -22.43% | -31.80% | Trim | |
| 2.4% | $22.63M | +20.70% | — | New | |
| 2.3% | $22.60M | -26.08% | -43.94% | Trim | |
| 2.3% | $21.99M | -16.07% | -8.21% | Trim | |
| 2.2% | $21.28M | +133.88% | -44.93% | Trim | |
| 2.0% | $18.82M | -18.77% | — | New | |
| 1.9% | $18.68M | -21.54% | +76.96% | Add | |
| 1.6% | $14.98M | +18.46% | +1.33% | Add | |
| 1.5% | $14.16M | -32.98% | +58.60% | Add | |
| 1.3% | $12.94M | +5.44% | -55.12% | Trim | |
| 1.3% | $12.65M | -22.68% | +32.67% | Add | |
| 1.3% | $12.53M | +0.94% | -2.58% | Trim | |
| 1.2% | $11.89M | -34.78% | — | New |
Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).
Largest buys in 2026 Q2
Largest sells in 2026 Q2
Options
Notional value, listed apart from stocks
ARK ETF TRNo ticker matchPUT$21.03MNew
SYNDAX PHARMACEUTICALS INCNo ticker matchCALL$15.16MAdd
ORIC PHARMACEUTICALS INCNo ticker matchCALL$7.39MNew
MONTE ROSA THERAPEUTICS INCNo ticker matchCALL$7.26MNew
ABIVAX SANo ticker matchCALL$6.66MNew
KYMERA THERAPEUTICS INCNo ticker matchPUT$2.87MNew
ABSCI CORPORATIONNo ticker matchPUT$1.83MNew
FULCRUM THERAPEUTICS INCNo ticker matchCALL$1.43MHold
Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.